日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The comparison of ZFNs, TALENs, and SpCas9 by GUIDE-seq in HPV-targeted gene therapy

通过 GUIDE-seq 对 ZFN、TALEN 和 SpCas9 在 HPV 靶向基因治疗中的比较

Zifeng Cui, Hui Liu, Hongfeng Zhang, Zhaoyue Huang, Rui Tian, Lifang Li, Weiwen Fan, Yili Chen, Lijie Chen, Sen Zhang, Bhudev C Das, Konstantin Severinov, Inga Isabel Hitzeroth, Priya Ranjan Debata, Zhuang Jin, Jiashuo Liu, Zheying Huang, Weiling Xie, Hongxian Xie, Bin Lang, Ji Ma, Haiyan Weng, Xun

In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs' cleavage by CRISPR/Cas13a system

通过 CRISPR/Cas13a 系统切割人乳头瘤病毒 E6/E7 mRNA 来抑制人宫颈癌细胞的体外和体内生长

Yili Chen, Hongye Jiang, Ting Wang, Dan He, Rui Tian, Zifeng Cui, Xun Tian, Qinglei Gao, Xin Ma, Jianrong Yang, Jun Wu, Songwei Tan, Hongyan Xu, Xiongzhi Tang, Yan Wang, Zhiying Yu, Hui Han, Bhudev C Das, Konstantin Severinov, Inga Isabel Hitzeroth, Priya Ranjan Debata, Wei Xu, Weiwen Fan, Zhuang Ji

Cytological Immunostaining of HMGA2, LRP1B, and TP63 as Potential Biomarkers for Triaging Human Papillomavirus-Positive Women

HMGA2、LRP1B 和 TP63 的细胞学免疫染色可作为对人乳头瘤病毒阳性女性进行分类的潜在生物标记

Yunhui Jiang, Chengyi Zhu, Dan He, Qinglei Gao, Xun Tian, Xin Ma, Jun Wu, Bhudev C Das, Konstantin Severinov, Inga Isabel Hitzeroth, Priya Ranjan Debata, Rong Liu, Liang Zou, Long Shi, Hua Xu, Kaixiu Wang, Yuxian Bao, Leung Ross Ka-Kit, Zeshan You, Zifeng Cui, Zheng Hu